TFF Pharmaceuticals (TFFP) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free TFFP Stock Alerts $1.93 +0.12 (+6.63%) (As of 03:45 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media TFF Pharmaceuticals Short Interest DataCurrent Short Volume123,800 sharesPrevious Short Volume69,700 sharesChange Vs. Previous Month+77.62%Dollar Volume Sold Short$337,974.00Short Interest Ratio / Days to Cover3.4Last Record DateApril 30, 2024Outstanding Shares2,520,000 sharesFloat Size3,040,000 sharesShort Percent of Float4.07%Today's Trading Volume25,234 sharesAverage Trading Volume30,776 sharesToday's Volume Vs. Average82% Short Selling TFF Pharmaceuticals ? Sign up to receive the latest short interest report for TFF Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTFFP Short Interest Over TimeTFFP Days to Cover Over TimeTFFP Percentage of Float Shorted Over Time Ad Paradigm PressBiden to Drop BOMBSHELL June 13th?Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th!Click here now to see his shocking evidence. TFF Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024123,800 shares $337,974.00 +77.6%4.1%3.4 $2.73 4/15/202469,700 shares $245,344.00 -19.5%2.8%2.2 $3.52 3/31/202486,600 shares $523,064.00 +86.6%3.4%3 $6.04 3/15/202446,400 shares $341,968.00 +156.4%2.0%1.8 $7.37 2/29/202418,100 shares $110,953.00 -11.3%0.8%0.8 $6.13 2/15/202420,400 shares $143,412.00 +0.5%0.9%1 $7.03 Get the Latest News and Ratings for TFFP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TFF Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/202420,300 shares $109,011.00 +36.2%0.9%1 $5.37 1/15/202414,900 shares $87,165.00 -15.8%0.6%0.8 $5.85 12/31/202317,700 shares $124,254.00 +342.5%0.8%1.1 $7.02 12/15/20234,000 shares $31,150.00 -94.9%0.2%0.3 $7.79 11/30/202377,600 shares $27,870.12 +134.4%N/A0.5 $0.36 11/15/202333,100 shares $7,368.06 +113.6%N/A0.2 $0.22 10/31/202315,500 shares $4,340.00 -48.5%N/A0.1 $0.28 10/15/202330,100 shares $10,685.50 -49.1%N/A0.2 $0.36 9/30/202359,100 shares $20,685.00 -20.6%N/A0.4 $0.35 9/15/202374,400 shares $29,760.00 -18.2%N/A0.4 $0.40 8/31/202391,000 shares $35,399.00 +94.9%N/A0.5 $0.39 8/15/202346,700 shares $19,147.00 -51.9%N/A0.2 $0.41 7/31/202397,000 shares $41,128.00 +11.8%N/A0.6 $0.42 7/15/202386,800 shares $28,470.40 -34.0%N/A0.5 $0.33 6/30/2023131,600 shares $61,852.00 -23.4%N/A0.9 $0.47 6/15/2023171,700 shares $80,699.00 +100.8%N/A1.3 $0.47 5/31/202385,500 shares $39,330.00 -37.8%N/A0.6 $0.46 5/15/2023137,400 shares $92,923.62 +1.0%N/A0.9 $0.68 4/30/2023136,000 shares $77,520.00 -35.0%N/A0.8 $0.57 4/15/2023209,200 shares $140,164.00 +37.6%N/A1.3 $0.67 3/31/2023152,000 shares $104,165.60 -13.2%N/A0.9 $0.69 3/15/2023175,100 shares $145,105.37 -24.9%N/A0.9 $0.83 2/28/2023233,100 shares $186,456.69 -52.6%N/A1.2 $0.80 2/15/2023492,000 shares $440,241.60 +2.5%N/A2.4 $0.89 1/31/2023479,900 shares $446,307.00 -15.4%N/A2.3 $0.93 1/15/2023567,500 shares $596,669.50 +2.8%2.3%2.2 $1.05 12/30/2022551,900 shares $579,495.00 -21.0%3.1%2.1 $1.05 12/15/2022698,500 shares $712,470.00 +13.3%3.9%2.7 $1.02 11/30/2022616,400 shares $745,844.00 -16.2%3.5%2.7 $1.21 11/15/2022735,500 shares $882,600.00 -10.6%3.5%3.5 $1.20 10/31/2022822,300 shares $2.06 million +16.8%3.9%5.5 $2.50 10/15/2022704,300 shares $2.14 million -10.5%3.4%7.5 $3.04 9/30/2022787,100 shares $3.20 million +14.1%3.8%8.9 $4.06 9/15/2022690,000 shares $3.94 million -13.4%3.3%8.5 $5.71How to Make 100X on the AI Boom (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs TFFP Short Interest - Frequently Asked Questions What is TFF Pharmaceuticals' current short interest? Short interest is the volume of TFF Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 123,800 shares of TFFP short. 4.07% of TFF Pharmaceuticals' shares are currently sold short. Learn More on TFF Pharmaceuticals' current short interest. What is a good short interest ratio for TFF Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TFFP shares currently have a short interest ratio of 3.0. Learn More on TFF Pharmaceuticals's short interest ratio. What is a good short interest percentage for TFF Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.07% of TFF Pharmaceuticals' floating shares are currently sold short. Is TFF Pharmaceuticals' short interest increasing or decreasing? TFF Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 123,800 shares, an increase of 77.6% from the previous total of 69,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TFF Pharmaceuticals' float size? TFF Pharmaceuticals currently has issued a total of 2,520,000 shares. Some of TFF Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TFF Pharmaceuticals currently has a public float of 3,040,000 shares. How does TFF Pharmaceuticals' short interest compare to its competitors? 4.07% of TFF Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to TFF Pharmaceuticals: Sonnet BioTherapeutics Holdings, Inc. (14.40%), Protagenic Therapeutics, Inc. (0.26%), Cingulate Inc. (0.20%), First Wave BioPharma, Inc. (2.39%), Hoth Therapeutics, Inc. (2.73%), Genprex, Inc. (2.46%), Xenetic Biosciences Inc (0.50%), Synaptogenix, Inc. (2.88%), Kintara Therapeutics, Inc. (10.35%), Oragenics, Inc. (2.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short TFF Pharmaceuticals stock? Short selling TFFP is an investing strategy that aims to generate trading profit from TFF Pharmaceuticals as its price is falling. TFFP shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TFF Pharmaceuticals? A short squeeze for TFF Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TFFP, which in turn drives the price of the stock up even further. How often is TFF Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TFFP, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Sonnet BioTherapeutics Short Interest Data Protagenic Therapeutics Short Interest Data Cingulate Short Interest Data First Wave BioPharma Short Interest Data Hoth Therapeutics Short Interest Data Genprex Short Interest Data Xenetic Biosciences Short Interest Data Synaptogenix Short Interest Data Kintara Therapeutics Short Interest Data Oragenics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TFFP) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportElon’s New Device is About to Shock the WorldInvestorPlaceAmerica’s worst nightmare?Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press